Abstract
Antisense oligonucleotide-mediated exon skipping is used to induce different dystrophin isoforms, one isoform missing amino acids encoded by DMD exons 56+57 and the other missing exons 58+59. Initial studies indicate that the latter is less functional, suggesting that mutations involving these exons may not respond to an exon skipping therapy.
Author supplied keywords
Cite
CITATION STYLE
APA
Li, D., Adams, A. M., Johnsen, R. D., Fletcher, S., & Wilton, S. D. (2020). Morpholino Oligomer-Induced Dystrophin Isoforms to Map the Functional Domains in the Dystrophin Protein. Molecular Therapy Nucleic Acids, 22, 263–272. https://doi.org/10.1016/j.omtn.2020.08.019
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free